AstraZeneca-Ranbaxy drug settlement not anti-competitive
In a landmark judgement for pharma sector, a US jury has ruled that AstraZeneca's patent litigation settlement for blockbuster drug Nexium with Ranbaxy was not anti-competitive.
Dec 06, 2014, 22:57 PM IST